Frances Bynum, OD: CooperVision: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); IntegraLifesciences: Speaker's Bureau (honoraria or other compensation) (); LKC Technologies: Speaker's Bureau (honoraria or other compensation) (); Macuhealth: Speaker's Bureau (honoraria or other compensation) ()
Tonya Reynoldson, OD MBA: No financial relationships to disclose
This continuing education course explores the ocular effects of systemic medications and nutritional supplements, including both adverse and therapeutic impacts. Emphasis will be placed on the clinical signs of drug-induced ocular toxicity, optometric management strategies, and the evidence supporting the use of ocular nutritional supplements. Optometrists will gain insights into monitoring protocols and co-management practices with other healthcare providers.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Identify common systemic medications that affect ocular structures and functions
Recognize the signs and symptoms of ocular side effects associated with medications
Understand the role of nutritional supplements in maintaining and improving eye health
Apply evidence-based guidelines in managing patients taking medications or supplements with ocular effects
Collaborate effectively with other healthcare providers in the co-management of patients experiencing ocular side effects
.jpg "Frances Bynum, OD photo")
